STUART NANCY (Chief Operating Officer) sold 2.3% of their position (6.05K shares) of CONCERT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $50.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/16/2023ACC: 0001209191-23-009951
Officer· Chief Operating Officer
Since Jul 2018
-6.05K
Net shares
Net seller
$50.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.05K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.05K
Price / share
$8.33
Trade value
$50.38K
% of position
2.3%
2/15/2023
268.64K→262.60K
Total
Net shares
−6.05K
Net value
-$50.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2023 | S · Sale | −6.05K | $8.33 | $50.38K | 2.3% | 268.64K | 262.60K |
| Total | −6.05K | -$50.38K | ||||||
Derivative Transactions0
No derivative transactions reported